Cargando…
Effect of AKT3 expression on MYC‐ and caspase‐8‐dependent apoptosis caused by polo‐like kinase inhibitors in HCT 116 cells
Polo‐like kinase (PLK) is a cell‐cycle regulator that is overexpressed in several cancer cell types. Polo‐like kinase is considered a novel target for cancer therapies, and several PLK inhibitors (PLKis), including BI 2536, BI 6727, and GSK461364, have been developed. In this study, we established f...
Autores principales: | Nonomiya, Yuma, Noguchi, Kohji, Tanaka, Noritaka, Kasagaki, Takahiro, Katayama, Kazuhiro, Sugimoto, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198950/ https://www.ncbi.nlm.nih.gov/pubmed/27699933 http://dx.doi.org/10.1111/cas.13093 |
Ejemplares similares
-
Heat shock protein 90 inhibitors overcome the resistance to Fms-like tyrosine kinase 3 inhibitors in acute myeloid leukemia
por: Katayama, Kazuhiro, et al.
Publicado: (2018) -
Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics
por: Noguchi, Kohji, et al.
Publicado: (2014) -
Induction of apoptosis by Dae-Hwang-Mok-Dan-Tang in HCT-116 colon cancer cells through activation of caspases and inactivation of the phosphatidylinositol 3-kinase/Akt signaling
por: Park, Cheol, et al.
Publicado: (2017) -
Ethanolic extract of Brucea javanica inhibit proliferation of HCT-116 colon cancer cells via caspase activation
por: Bagheri, E., et al.
Publicado: (2018) -
RSK1 protects P-glycoprotein/ABCB1 against ubiquitin–proteasomal degradation by downregulating the ubiquitin-conjugating enzyme E2 R1
por: Katayama, Kazuhiro, et al.
Publicado: (2016)